Cargando…

Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics

BACKGROUND: Peripheral neuropathy (PN) is a common complication in obesity, prediabetes, and type 2 diabetes, though its pathogenesis remains incompletely understood. In a murine high-fat diet (HFD) obesity model of PN, dietary reversal (HFD-R) to a low-fat standard diet (SD) restores nerve function...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Kai, Figueroa-Romero, Claudia, Noureldein, Mohamed, Hinder, Lucy M., Sakowski, Stacey A., Rumora, Amy E., Petit, Hayley, Savelieff, Masha G., Hur, Junguk, Feldman, Eva L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015923/
https://www.ncbi.nlm.nih.gov/pubmed/36922895
http://dx.doi.org/10.1186/s40168-022-01436-3
_version_ 1784907301905235968
author Guo, Kai
Figueroa-Romero, Claudia
Noureldein, Mohamed
Hinder, Lucy M.
Sakowski, Stacey A.
Rumora, Amy E.
Petit, Hayley
Savelieff, Masha G.
Hur, Junguk
Feldman, Eva L.
author_facet Guo, Kai
Figueroa-Romero, Claudia
Noureldein, Mohamed
Hinder, Lucy M.
Sakowski, Stacey A.
Rumora, Amy E.
Petit, Hayley
Savelieff, Masha G.
Hur, Junguk
Feldman, Eva L.
author_sort Guo, Kai
collection PubMed
description BACKGROUND: Peripheral neuropathy (PN) is a common complication in obesity, prediabetes, and type 2 diabetes, though its pathogenesis remains incompletely understood. In a murine high-fat diet (HFD) obesity model of PN, dietary reversal (HFD-R) to a low-fat standard diet (SD) restores nerve function and the nerve lipidome to normal. As the gut microbiome represents a potential link between dietary fat intake and nerve health, the current study assessed shifts in microbiome community structure by 16S rRNA profiling during the paradigm of dietary reversal (HFD-R) in various gut niches. Dietary fat content (HFD versus SD) was also correlated to gut flora and metabolic and PN phenotypes. Finally, PN-associated microbial taxa that correlated with the plasma and sciatic nerve lipidome and nerve transcriptome were used to identify lipid species and genes intimately related to PN phenotypes. RESULTS: Microbiome structure was altered in HFD relative to SD but rapidly reversed with HFD-R. Specific taxa variants correlating positively with metabolic health associated inversely with PN, while specific taxa negatively linked to metabolic health positively associated with PN. In HFD, PN-associated taxa variants, including Lactobacillus, Lachnoclostridium, and Anaerotruncus, also positively correlated with several lipid species, especially elevated plasma sphingomyelins and sciatic nerve triglycerides. Negative correlations were additionally present with other taxa variants. Moreover, relationships that emerged between specific PN-associated taxa variants and the sciatic nerve transcriptome were related to inflammation, lipid metabolism, and antioxidant defense pathways, which are all established in PN pathogenesis. CONCLUSIONS: The current results indicate that microbiome structure is altered with HFD, and that certain taxa variants correlate with metabolic health and PN. Apparent links between PN-associated taxa and certain lipid species and nerve transcriptome-related pathways additionally provide insight into new targets for microbiota and the associated underlying mechanisms of action in PN. Thus, these findings strengthen the possibility of a gut-microbiome-peripheral nervous system signature in PN and support continuing studies focused on defining the connection between the gut microbiome and nerve health to inform mechanistic insight and therapeutic opportunities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40168-022-01436-3.
format Online
Article
Text
id pubmed-10015923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100159232023-03-16 Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics Guo, Kai Figueroa-Romero, Claudia Noureldein, Mohamed Hinder, Lucy M. Sakowski, Stacey A. Rumora, Amy E. Petit, Hayley Savelieff, Masha G. Hur, Junguk Feldman, Eva L. Microbiome Research BACKGROUND: Peripheral neuropathy (PN) is a common complication in obesity, prediabetes, and type 2 diabetes, though its pathogenesis remains incompletely understood. In a murine high-fat diet (HFD) obesity model of PN, dietary reversal (HFD-R) to a low-fat standard diet (SD) restores nerve function and the nerve lipidome to normal. As the gut microbiome represents a potential link between dietary fat intake and nerve health, the current study assessed shifts in microbiome community structure by 16S rRNA profiling during the paradigm of dietary reversal (HFD-R) in various gut niches. Dietary fat content (HFD versus SD) was also correlated to gut flora and metabolic and PN phenotypes. Finally, PN-associated microbial taxa that correlated with the plasma and sciatic nerve lipidome and nerve transcriptome were used to identify lipid species and genes intimately related to PN phenotypes. RESULTS: Microbiome structure was altered in HFD relative to SD but rapidly reversed with HFD-R. Specific taxa variants correlating positively with metabolic health associated inversely with PN, while specific taxa negatively linked to metabolic health positively associated with PN. In HFD, PN-associated taxa variants, including Lactobacillus, Lachnoclostridium, and Anaerotruncus, also positively correlated with several lipid species, especially elevated plasma sphingomyelins and sciatic nerve triglycerides. Negative correlations were additionally present with other taxa variants. Moreover, relationships that emerged between specific PN-associated taxa variants and the sciatic nerve transcriptome were related to inflammation, lipid metabolism, and antioxidant defense pathways, which are all established in PN pathogenesis. CONCLUSIONS: The current results indicate that microbiome structure is altered with HFD, and that certain taxa variants correlate with metabolic health and PN. Apparent links between PN-associated taxa and certain lipid species and nerve transcriptome-related pathways additionally provide insight into new targets for microbiota and the associated underlying mechanisms of action in PN. Thus, these findings strengthen the possibility of a gut-microbiome-peripheral nervous system signature in PN and support continuing studies focused on defining the connection between the gut microbiome and nerve health to inform mechanistic insight and therapeutic opportunities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40168-022-01436-3. BioMed Central 2023-03-15 /pmc/articles/PMC10015923/ /pubmed/36922895 http://dx.doi.org/10.1186/s40168-022-01436-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guo, Kai
Figueroa-Romero, Claudia
Noureldein, Mohamed
Hinder, Lucy M.
Sakowski, Stacey A.
Rumora, Amy E.
Petit, Hayley
Savelieff, Masha G.
Hur, Junguk
Feldman, Eva L.
Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title_full Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title_fullStr Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title_full_unstemmed Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title_short Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
title_sort gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015923/
https://www.ncbi.nlm.nih.gov/pubmed/36922895
http://dx.doi.org/10.1186/s40168-022-01436-3
work_keys_str_mv AT guokai gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT figueroaromeroclaudia gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT noureldeinmohamed gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT hinderlucym gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT sakowskistaceya gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT rumoraamye gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT petithayley gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT savelieffmashag gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT hurjunguk gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics
AT feldmaneval gutmicrobiotainamousemodelofobesityandperipheralneuropathyassociatedwithplasmaandnervelipidomicsandnervetranscriptomics